Perceptive Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.28M | Sell |
|
|||||
|
2025
Q1 | $10.9M | Hold |
|
|||||
|
2024
Q4 | $12.8M | Sell |
|
|||||
|
2024
Q3 | $20.7M | Sell |
|
|||||
|
2024
Q2 | $22.7M | Sell |
|
|||||
|
2024
Q1 | $38.4M | Sell |
|
|||||
|
2023
Q4 | $50.7M | Buy |
|
|||||
|
2023
Q3 | $21.1M | Sell |
|
|||||
|
2023
Q2 | $47.1M | Sell |
|
|||||
|
2023
Q1 | $65.6M | Sell |
|
|||||
|
2022
Q4 | $75.8M | Sell |
|
|||||
|
2022
Q3 | $76.6M | Hold |
|
|||||
|
2022
Q2 | $64.6M | Sell |
|
|||||
|
2022
Q1 | $73.7M | Hold |
|
|||||
|
2021
Q4 | $75.3M | Buy |
|
|||||
|
2021
Q3 | $30.9M | Buy |
|
|||||
|
2021
Q2 | $31.3M | Buy |
|
|||||
|
2021
Q1 | $9.22M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $2.28M | Hold |
|
|||||
|
2017
Q1 | $2.9M | Sell |
|
|||||
|
2016
Q4 | $5.7M | Sell |
|
|||||
|
2016
Q3 | $6.18M | Buy |
|
|||||
|
2016
Q2 | $2.55M | Buy |
|
|||||
|
2016
Q1 | $1.44M | Hold |
|
|||||
|
2015
Q4 | $1.66M | Hold |
|
|||||
|
2015
Q3 | $1.7M | Sell |
|
|||||
|
2015
Q2 | $2.59M | Hold |
|
|||||
|
2015
Q1 | $3.79M | Hold |
|
|||||
|
2014
Q4 | $4.44M | Buy |
|